Summary:
This study is to see how well the medication is on preventing and slowing down the rate of liver function decline for volunteers with Asthma.
Qualified Participants Must:
• Eighteen years of age and older
• Diagnosis of Asthma for at least one year
• Treatment with medium to high dose ICS (Fluticasone proplonate) in combinition with a second controller. No history of COPD or any other lung disease
• current smoker
Qualified Participants May Receive:
Qualified participants will receive compensation for each visit, medical care, and medication at no cost. We also provide complimentary transportation.